| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2006 | US20060165657 Method for delivery of cosmetic by topical application |
| 07/27/2006 | US20060165634 Advanced cell-transducing transport domain-target protein-transport domain fusion protein and uses thereof |
| 07/27/2006 | US20060165613 High performance in detergent compositions; superior cleaning and stain removal; cleaning a fabric, a dishware or hard surface |
| 07/27/2006 | US20060165592 Nk cell receptor conjugates for treating malignancies |
| 07/27/2006 | US20060165313 Scanned image alignment systems and methods |
| 07/27/2006 | US20060163393 Apparatus and method for automatically defibering and extracting kraft pulp from old corrugated cardboard |
| 07/27/2006 | DE4390683B4 Gallensäuresulfat-Sulfatasegen, Plasmid, das dieses Gen enthält, und Verfahren zur Herstellung von Gallensäuresulfat-Sulfatase Bile acid sulfate Sulfatasegen, plasmid containing this gene, and methods for the preparation of bile acid sulfate sulfatase |
| 07/27/2006 | DE19929485B4 Lytisches Enzym Lytic enzyme |
| 07/27/2006 | DE19858777B4 Verfahren zur teilweisen oder vollständigen Trennung von glykosilierten und nicht-glykosilierten Proteinen A process for the partial or complete separation of glycosylated and non-glycosylated proteins, |
| 07/27/2006 | DE102005003207A1 Lentivirales Gentransfersystem für Ribozym-vermittelte RNA-Reparatur The lentiviral gene transfer system for ribozyme-mediated RNA repair |
| 07/27/2006 | DE102005002353A1 Use of receptor multimerization epitope (RME) of advanced glycation end product receptor (AGER) as immunogen, useful for preparing antibodies for diagnosis and treatment of e.g. spinal injuries or diabetic complications |
| 07/27/2006 | DE102004058306A1 Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden A process for the production of carboxy-terminal amidated peptides |
| 07/27/2006 | DE10101962B4 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins |
| 07/27/2006 | CA2601324A1 Polypeptide mutagenesis method |
| 07/27/2006 | CA2595803A1 Novel polyester-based-plastic-degrading bacteria, polyester-based-plastic-degrading enzymes and polynucleotides encoding the enzymes |
| 07/27/2006 | CA2595704A1 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids |
| 07/27/2006 | CA2595629A1 Vaccines based on the use of mva |
| 07/27/2006 | CA2595590A1 Free reactant use in nucleic acid-templated synthesis |
| 07/27/2006 | CA2595528A1 Method of treatment by administration of rna |
| 07/27/2006 | CA2595501A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family having a pathway of glycogen biosynthesis disrupted |
| 07/27/2006 | CA2595462A1 Hla fusion molecules and uses thereof |
| 07/27/2006 | CA2595084A1 Method for coating particle with lipid film |
| 07/27/2006 | CA2595074A1 Mycobacteria with mannose cap-deficient lipoarabinomannan |
| 07/27/2006 | CA2595056A1 Method for producing a compound of interest in a filamentous fungal cell |
| 07/27/2006 | CA2594629A1 Fibrosis inhibitor for implanted organ |
| 07/27/2006 | CA2594358A1 Improving embryo development and survival |
| 07/27/2006 | CA2593520A1 Recombinant expression of proteins in a disulfide-bridged, two-chain form |
| 07/27/2006 | CA2570165A1 Transcriptional termination of transgene expression using host genomic terminators |
| 07/27/2006 | CA2567446A1 Alphavirus vectors for respiratory pathogen vaccines |
| 07/27/2006 | CA2563538A1 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 07/27/2006 | CA2562685A1 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 07/26/2006 | EP1684312A2 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 07/26/2006 | EP1684073A2 Target sequences for synthetic molecules and methods of using same |
| 07/26/2006 | EP1683874A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 07/26/2006 | EP1683871A2 Nucleic acid ligands and methods for producing the same |
| 07/26/2006 | EP1683870A1 Vaccines based on the use of MVA |
| 07/26/2006 | EP1683868A1 Kringle domains in a calcium sensor fusion protein |
| 07/26/2006 | EP1683867A1 Groups of Borrelia burgdorferi and Borrelia afzelii that cause lyme disease in humans |
| 07/26/2006 | EP1683866A2 Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof |
| 07/26/2006 | EP1683865A2 Mammalian proteins and in particular CD200 |
| 07/26/2006 | EP1683864A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/26/2006 | EP1683863A2 A method for enhancing neurone survival and agents useful for same |
| 07/26/2006 | EP1683861A1 In vitro method for obtaining recombined polynucleotide sequences, sequence libraries and resulting sequences |
| 07/26/2006 | EP1683860A2 Novel endoglucanases |
| 07/26/2006 | EP1683858A2 Viral preparations, vectors, immunogens, and vaccines |
| 07/26/2006 | EP1683855A1 Cell capturing apparatus and method of capturing cell |
| 07/26/2006 | EP1683811A2 Compositions and methods for the treatment of tumors |
| 07/26/2006 | EP1683807A1 Combination products for use in antitumoral treatment, comprising an antibody capable of inhibiting the activity of CSF-1 |
| 07/26/2006 | EP1683527A1 Method of inhibiting secretase activity |
| 07/26/2006 | EP1682682A2 Compositions and methods for modulating c-rel-dependent cytokine production |
| 07/26/2006 | EP1682678A2 Device and method for high-throughput quantification of mrna from whole blood |
| 07/26/2006 | EP1682668A2 Plant transcriptional regulators |
| 07/26/2006 | EP1682667A2 Rna virus-derived plant expression system |
| 07/26/2006 | EP1682666A1 Hiv pharmaccines |
| 07/26/2006 | EP1682665A2 Use of fibroblast growth factor fragments |
| 07/26/2006 | EP1682664A2 Methods for the production of apolipoproteins in transgenic plants |
| 07/26/2006 | EP1682663A2 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682662A1 Nucleic acids specifically binding bioactive ghrelin |
| 07/26/2006 | EP1682661A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 07/26/2006 | EP1682660A2 RNA INTERFERANCE MEDIATED INHIBITION OF CHOLINERGIC MUSCARINIC RECEPTOR (CHRM3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/26/2006 | EP1682657A2 Gene |
| 07/26/2006 | EP1682656A1 Polypeptides having beta-glucosidase activity and polynucleotides encoding same |
| 07/26/2006 | EP1682655A1 Carbohydrate-binding modules of a new family |
| 07/26/2006 | EP1682651A2 Improvements in cell growth |
| 07/26/2006 | EP1682650A1 Construction of new xylose utilizing saccharomyces cerevisiae strain |
| 07/26/2006 | EP1682584A1 A pharmaceutical composition comprising an immunoglobulin fc region as a carrier |
| 07/26/2006 | EP1682583A1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 07/26/2006 | EP1682582A1 Method for the mass production of immunoglobulin constant region |
| 07/26/2006 | EP1682581A1 Igg fc fragment for a drug carrier and method for the preparation thereof |
| 07/26/2006 | EP1682576A1 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
| 07/26/2006 | EP1682574A2 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 07/26/2006 | EP1682573A2 The use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferattive diseases |
| 07/26/2006 | EP1682569A2 Cellular membrane protein assay |
| 07/26/2006 | EP1682568A2 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 07/26/2006 | EP1682567A2 Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast |
| 07/26/2006 | EP1682566A2 Delta-15 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous plants and yeast |
| 07/26/2006 | EP1682565A1 Iap nucleobase oligomers and oligomeric complexes and uses thereof |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682073A2 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 07/26/2006 | EP1681988A2 Method for diagnosis and treatment of pulmonary disorders |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1546378A4 Microarrays and method for running hybridization reaction for multiple samples on a single microarray |
| 07/26/2006 | EP1481065B1 Method for detection of leptin receptor ligands |
| 07/26/2006 | EP1465921B1 Corticotropin releasing factor receptor 2 agonists |
| 07/26/2006 | EP1461350A4 Multiplex real-time quantitative pcr |
| 07/26/2006 | EP1449917B1 Process for producing l-amino acid using escherichia |
| 07/26/2006 | EP1438411B1 Use of aminoglycoside resistance gene |
| 07/26/2006 | EP1404856B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 07/26/2006 | EP1395681B1 Pharmacological applications of mitochondrial dna assays |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1364060B1 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351974B1 Using viruses to detect or purify proteins |
| 07/26/2006 | EP1351703B1 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 07/26/2006 | EP1311690B1 Human proteases and polynucleotides encoding the same |
| 07/26/2006 | EP1278889B1 Hybridisation beacon and method of rapid sequence detection and discrimination |
| 07/26/2006 | EP1263784B1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1222311B1 Electrochemiluminescence helicase assay |